2011
DOI: 10.1590/s1677-55382011000200003 View full text |Buy / Rent full text
|
|

Abstract: The combined use of radiation therapy (RT) and androgen deprivation for patients with localized high-risk prostate cancer is commonly accepted as the standard treatment among uro-oncologists. Preclinical studies have provided rationale for the use of this combination. Additionally, results of phase 3 studies using conventional doses of RT have supported the combined approach. Other phase 3 studies have also shown a benefit for using higher doses of RT; however, the role of androgen deprivation in this context … Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
7
0

Publication Types

Select...

Relationship

0
0

Authors

Journals